Reviewer Guidelines

Accepting an Invitation

IJAPS relies on independent experts to assess every manuscript. Before accepting an invitation, please check that:

• the manuscript falls within your area of expertise;
• you can complete the review within 3 weeks (please tell us early if you need more time);
• you have no conflict of interest – for example, a recent collaboration, the same institution, or a financial or personal interest. If in doubt, ask the editor.

Invitations are sent through the journal’s submission system. Register as a reviewer and add your areas of interest to your profile.

Confidentiality & Conduct

• Treat the manuscript as confidential. Do not share it, discuss it with others or use its content before publication.
• Do not upload the manuscript or any part of it to generative AI tools.
• Do not try to identify the authors; IJAPS uses double-blind review.
• Do not suggest citations to your own work unless they are genuinely needed.
• Tell the editor if you suspect plagiarism, data fabrication, duplicate publication or an ethics problem.

What to Assess

• Originality and relevance: does the work add to knowledge in the pharmaceutical sciences?
• Methods: are the design, sample size, analytical methods and statistics appropriate and described in enough detail to be repeated?
• Results and conclusions: are they supported by the data?
• Ethics: are ethics approval, consent and conflict-of-interest statements provided where needed?
• Presentation: are the title, abstract, figures, tables and references accurate and clear?

Writing the Report

Please give a short summary of the manuscript, followed by major and minor comments numbered so that the authors can reply point by point. Be specific, constructive and courteous. Confidential comments for the editor can be entered separately.

Recommend one of: Accept, Minor revision, Major revision or Reject. The final decision is made by the editor, taking all reviews into account.

Reviewers who complete reviews may request a review certificate from the editorial office.